from Argus Research issued a price target of $95.00 for DAL on 2026-10-12 13:06:30.The adjusted price target was set to $95.00.At the time of the announcement, DAL was trading at $80.79.The overall price target consensus is at $103.14 with high price of $125.00, low price of $85.00, and median price is at $101.50.DAL currently trades...
Thomas Palmer from Coker Palmer issued a price target of $75.00 for ADM on 2026-10-12 12:41:50.The...
from BMO Capital issued a price target of $105.00 for DAL on 2026-10-12 12:40:57.The adjusted price...
Brad Zelnick from Deutsche Bank issued a price target of $600.00 for MSFT on 2026-10-12 12:38:24.The...
from BTIG issued a price target of $99.00 for MDT on 2026-10-12 12:31:23.The adjusted price target...
from Argus Research issued a price target of $95.00 for DAL on 2026-10-12 13:06:30.The adjusted price target was set to $95.00.At the time of the announcement, DAL was trading at...
Thomas Palmer from Coker Palmer issued a price target of $75.00 for ADM on 2026-10-12 12:41:50.The adjusted price target was set to $75.00.At the time of the announcement, ADM was...
from BMO Capital issued a price target of $105.00 for DAL on 2026-10-12 12:40:57.The adjusted price target was set to $105.00.At the time of the announcement, DAL was trading at...
Brad Zelnick from Deutsche Bank issued a price target of $600.00 for MSFT on 2026-10-12 12:38:24.The adjusted price target was set to $600.00.At the time of the announcement, MSFT was...
from BTIG issued a price target of $99.00 for MDT on 2026-10-12 12:31:23.The adjusted price target was set to $99.00.At the time of the announcement, MDT was trading at $92.46.The...
In the first quarter of 2025, the company faced revenue declines, largely due to Paxlovid, while operational expenses surged. Management is committed to enhancing R&D productivity and optimizing capital allocation,...
In a landscape of fluctuating markets and regulatory uncertainties, the company experienced a remarkable revenue surge, reaching $36,077 million. Despite operational challenges, net income stood at $7,713 million. Management emphasized...
In the bustling corridors of Merck, management reflects on a transformative quarter. With net income rising to 5,085 million, the company celebrates strategic wins in oncology and diabetes, driven by...
In 2025, the company embraced growth through increased research and development, despite rising operating expenses. A net income of $24,780 million marked a decline, reflecting challenges in a fluctuating market....
In the first quarter of 2025, the company experienced a 9% revenue growth, fueled by increased sales and services. Operating expenses rose, reflecting evolving cost structures, while net income showed...
In a significant update from Wall Street, top analysts have recently shifted their outlooks on several prominent companies, reflecting a broader trend in the technology sector. This comes as Amazon...
CARTERRA, a prominent player in high-throughput surface plasmon resonance (HT-SPR™) technology for drug discovery, has announced its involvement in significant research published by Google DeepMind in the prestigious journal *Nature*....
Nvidia Corp (NASDAQ: NVDA, XETRA: NVD), the prominent American chipmaker, is reportedly considering an acquisition of the artificial intelligence startup Reflection AI or potentially increasing its investment in the company...
In an era marked by unprecedented investments in artificial intelligence (AI), tech giants Oracle and Broadcom have taken markedly different approaches to capitalize on this burgeoning sector. Both organizations are...
In a significant development for Microsoft Corp and its subsidiaries, Norway's data protection authority has imposed a hefty fine of 92 million kroner, equivalent to approximately 8.6 million euros, on...
